Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Premier is first company allowed access to CMS data

The Centers for Medicare & Medicaid Services (CMS) has granted Premier access to its Virtual Research Data Center (VRDC) to develop innovations that drive healthcare transformation.

Initiative in Israel reduces use of diagnostic testing and saves hospital money

An initiative in Israel that included systematic feedback and monitoring helped reduce the use of common laboratory and other diagnostic tests.

Missouri Hospital Association's consumer website adds pricing data

The Missouri Hospital Association’s consumer-focused website, Focus on Hospitals, now offers pricing data for participating Missouri hospitals.

Thumbnail

NQF’s Measure Applications Partnership offers recommendations

The National Quality Forum’s Measure Applications Partnership (MAP) has submitted recommendations to the Department of Health and Human Services for approximately 140 performance measures under consideration for use in 16 federal healthcare programs.

Thumbnail

Abbott agrees to acquire Alere for $5.8 billion

Abbott has agreed to acquire point-of-care diagnostics company Alere for approximately $5.8 billion, the companies announced this week. 

Thumbnail

Proposed rule changes ACO benchmarks

The Centers for Medicare & Medicaid Services (CMS) released a proposed rule to update the methodology used to measure the performance of accountable care organizations (ACOs) in the Medicare Shared Savings Program.

Livanta Selects InterQual to Support its Medicare Utilization and Quality Care Reviews

The BFCC-QIO will use InterQual evidence-based criteria for two-midnight short-stay reviews.

Thumbnail

Examining the benefits of large-scale insurance mergers

Mergers of large health insurance companies have been in the news in recent months, but an editorial from Health Affairs suggests it remains to be seen if such deals are truly beneficial. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.